Advanced colorectal cancer harbors extensive intratumor heterogeneity shaped by neutral evolution; however, intratumor heterogeneity in colorectal precancerous lesions has been poorly studied. We perform multiregion whole-exome sequencing on ten early colorectal tumors, which contained adenoma and carcinoma in situ. By comparing with sequencing data from advanced colorectal tumors, we show that the early tumors accumulate a higher proportion of subclonal driver mutations than the advanced tumors, which is highlighted by subclonal mutations in KRAS and APC. We also demonstrate that variant allele frequencies of subclonal mutations tend to be higher in early tumors, suggesting that the subclonal mutations are subject to selective sweep in ear...
Summary: Tumor multiregion sequencing reveals intratumor heterogeneity (ITH) and clonal evolution pl...
<div><p>Intratumor heterogeneity (ITH) leads to an underestimation of the mutational landscape portr...
Abstract Colorectal cancer (CRC) has a global burden of disease. Our current understanding of CRC ha...
<div><p>Understanding intratumor heterogeneity is clinically important because it could cause therap...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
We thank João Neto and remaining Computational Multi-Omics Lab members at UCIBIO for their helpful c...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
Summary: Tumor multiregion sequencing reveals intratumor heterogeneity (ITH) and clonal evolution pl...
<div><p>Intratumor heterogeneity (ITH) leads to an underestimation of the mutational landscape portr...
Abstract Colorectal cancer (CRC) has a global burden of disease. Our current understanding of CRC ha...
<div><p>Understanding intratumor heterogeneity is clinically important because it could cause therap...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
We thank João Neto and remaining Computational Multi-Omics Lab members at UCIBIO for their helpful c...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
Evolution of intratumoral genetic heterogeneity during colorectal tumor progression has not been inv...
The evolutionary events that cause colorectal adenomas (benign) to progress to carcinomas (malignant...
Summary: Tumor multiregion sequencing reveals intratumor heterogeneity (ITH) and clonal evolution pl...
<div><p>Intratumor heterogeneity (ITH) leads to an underestimation of the mutational landscape portr...
Abstract Colorectal cancer (CRC) has a global burden of disease. Our current understanding of CRC ha...